A study that sought to replicate the effects of vaping on lung cells found that vapor from e-cigarettes boosts the production of inflammatory chemicals and disables key protective cells in the lung that engulf potentially harmful particles. Some of the effects were similar to those seen in regular smokers and people with chronic obstructive pulmonary disease.
A study that sought to replicate the effects of vaping on lung cells found that vapor from e-cigarettes boosts the production of inflammatory chemicals and disables key protective cells in the lung that engulf potentially harmful particles.
The study, published online in the journal Thorax, said e-cigarettes may be more harmful than believed, as some of the effects were similar to those seen in regular smokers and people with chronic obstructive pulmonary disease (COPD). Regular use of electronic cigarettes is associated with increased odds of having COPD, according to 1 recent study.
The vapor impairs the activity of alveolar macrophages (AM), which engulf and remove dust particles, bacteria, and allergens that have evaded the other mechanical defenses of the respiratory tract.
Vaping is increasing in popularity, but most current research has focused on the chemical composition of e-cigarette liquid before it is vaped.
The researchers said this is the first study to report human AM responses to e-cigarette vapor condensate (ECVC) and demonstrates dose-dependent cytotoxicity, inducing cell death, with both nicotine-dependent and independent responses, which the vaping process accentuates. At sub-cytotoxic doses, ECVC enhances production of reactive oxygen species (ROS) release, inflammatory cytokines, chemokines, and metalloproteinases, although the response is less pronounced with nicotine-free ECVC. Bacterial phagocytosis by macrophages is inhibited acutely by ECVC, and the effects are attenuated by the antioxidant N-acetyl-cysteine, suggesting ROS and reactive aldehydes play a role in the effects of ECVC/nfECVC.
These effects appear to be partially dependent on phosphopinositol 3 kinase (PI3K). ROS-induced lung inflammation in COPD has been reported to be associated with activation with PI3K.
The researchers devised a mechanical procedure to mimic vaping and produce condensate from the vapor. They extracted alveolar macrophages from lung tissue samples provided by 8 nonsmokers who had never had asthma or COPD.
One-third of the cells were exposed to plain e-cigarette fluid, one-third to different strengths of the artificially vaped condensate with and without nicotine, and one-third to nothing for 24 hours. The results showed that the condensate was significantly more harmful to the cells than e-cigarette fluid and that these effects worsened as the dose increased.
After 24 hours of exposure, the total number of viable cells exposed to the vaped condensate was significantly reduced compared to the untreated cells. Condensate containing nicotine exaggerated this effect.
Exposure to the condensate increased cell death and boosted production of oxygen-free radicals by 50-fold. It significantly increased the production of inflammatory chemicals, even more so when the condensate contained nicotine.
The ability of cells exposed to vaped condensate to engulf bacteria was significantly impaired, although treatment with an antioxidant restored this function and helped lessen some of the other harmful effects.
The researchers conclude that the vaping process itself can damage vital immune system cells in a way similar to that observed in cigarette smokers and in patients with COPD, at least under laboratory conditions.
Reference
Scott A, Lugg ST, Aldridge K, et al. Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages. [published online August 13, 2018]. Thorax. doi: 10.1136/thoraxjnl-2018-211663.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More